SBIR/STTR Research Award

Nutritional Intervention for Older Adult Muscle Loss

Award identifier 46b80d4e5ac897a7f4b85ac93c4888e70f3025d9d930b65bebed47e9c587c519Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,001

Program and phase

SBIR · Phase I

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
MTI Biotech Incorporated
Proposal award date
Not reported
Contract end date
Not reported
UEI
N5NDNJL8QGA1
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Age-related muscle loss is a major public health issue affecting over 30 million Americans, with no viable treatments available to stem about an 8% loss in muscle mass every decade. Preliminary studies with beta-hydroxy-beta-methylbutyrate, arginine, and lysine (HMB/ARG/LYS) indicate a reversal of age-related muscle loss is possible, at least with women. Limited data collection on elderly men suggest HMB/ARG/LYS may not have an effect. The proposed study will expand on these preliminary studies in women to determine whether a combination of HMB, arginine, and lysine is effective in increasing whole body protein synthesis, fat-free mass, strength and functionality in both older adult men and women. Thirty-two subjects (16 men and 16 women) over the age of 65 years will be recruited and will be assigned to an isonitrogenous control treatment (n=16) or to the experimental treatment group (n=l 6) containing HMB (calcium salt), arginine, and lysine daily (HMB/ARG/LYS) for six weeks. Whole body protein turnover, body composition, strength and functionality will be used as measures of effectiveness. It is hypothesized that this mixture will support maximal protein synthesis and minimize proteolysis resulting in an increase in net protein balance. If proven effective in Phase I, the overall objective of Phase II of this research will be to test the long-term (12 month) efficacy of this nutrient mixture to prevent and reverse the loss of muscle mass, strength, and functionality that occurs in older adults.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

17 SBIR/STTR records share this UEI (1995–2023). Reported award amounts total $8,355,488. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services, Department of Agriculture, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.